FCE News https://fcenews.it/index.php 2016-06-21T07:56:14Z Joomla! 1.5 - Open Source Content Management Progress in the treatment of ovarian cancer--lessons from homologous recombination deficiency--the first 10 years 2016-05-04T08:00:00Z 2016-05-04T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=210340:progress-treatment-ovarian-cancer&catid=1005:Oncologia&Itemid=126 Annals of Oncology - recent issues [email protected] Oncologia

For several years, a major obstacle in the systemic treatment of ovarian cancer has been the lack of a therapeutic strategy tailored to specific biomarkers present in the individual patient's tumour. However, considerable progress has been made ... ...

Oncologia

For several years, a major obstacle in the systemic treatment of ovarian cancer has been the lack of a therapeutic strategy tailored to specific biomarkers present in the individual patient's tumour. However, considerable progress has been made ... ... Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer 2016-05-04T08:00:00Z 2016-05-04T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=210341:epithelial-ovarian-cancer-molecular&catid=1005:Oncologia&Itemid=126 Annals of Oncology - recent issues [email protected]

OncologiaBackground

Epithelial ovarian cancer (EOC) remains one of the leading causes of cancer-related deaths among women worldwide, despite gains in diagnostics and treatments made over the last three decades. Existing markers of ovarian c ... ...

OncologiaBackground

Epithelial ovarian cancer (EOC) remains one of the leading causes of cancer-related deaths among women worldwide, despite gains in diagnostics and treatments made over the last three decades. Existing markers of ovarian c ... ... Opportunities in immunotherapy of ovarian cancer 2016-05-04T08:00:00Z 2016-05-04T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=210342:opportunities-immunotherapy-ovarian-cancer&catid=1005:Oncologia&Itemid=126 Annals of Oncology - recent issues [email protected]

Oncologia

Ovarian cancer (OC) is the most important cause of gynecological cancer-related mortality, with the majority of women presenting with advanced disease. Although surgery and chemotherapy can improve survival, the 5-year survival rates remain omino ... ...

Oncologia

Ovarian cancer (OC) is the most important cause of gynecological cancer-related mortality, with the majority of women presenting with advanced disease. Although surgery and chemotherapy can improve survival, the 5-year survival rates remain omino ... ... The molecular pathology of ovarian serous borderline tumors 2016-05-04T08:00:00Z 2016-05-04T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=210343:molecular-pathology-ovarian-serous&catid=1005:Oncologia&Itemid=126 Annals of Oncology - recent issues [email protected]

Oncologia

Molecular studies in ovarian serous borderline tumors (OSBTs) have been used to understand different aspects of this neoplasm. (i) Pathogenesis, Kras and Braf mutations represent very early events in the tumorigenesis of OSBT as both are detected ... ...

Oncologia

Molecular studies in ovarian serous borderline tumors (OSBTs) have been used to understand different aspects of this neoplasm. (i) Pathogenesis, Kras and Braf mutations represent very early events in the tumorigenesis of OSBT as both are detected ... ... Management of borderline ovarian tumors 2016-05-04T08:00:00Z 2016-05-04T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=210344:management-borderline-ovarian-tumors&catid=1005:Oncologia&Itemid=126 Annals of Oncology - recent issues [email protected]

OncologiaBackground

Borderline ovarian tumors (BOT) are epithelial tumors of the ovaries with both malignant and non-malignant aspects. On the one hand, they are characterized by cellular proliferation and nuclear atypia but, on the other ha ... ...

OncologiaBackground

Borderline ovarian tumors (BOT) are epithelial tumors of the ovaries with both malignant and non-malignant aspects. On the one hand, they are characterized by cellular proliferation and nuclear atypia but, on the other ha ... ... Molecular imaging in ovarian cancer 2016-05-04T08:00:00Z 2016-05-04T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=210345:molecular-imaging-ovarian-cancer&catid=1005:Oncologia&Itemid=126 Annals of Oncology - recent issues [email protected]

Oncologia

Ovarian cancer has a high mortality and novel-targeted treatment strategies have not resulted in breakthroughs for this disease. Insight into the molecular characteristics of ovarian tumors may improve diagnosis and selection of patients for trea ... ...

Oncologia

Ovarian cancer has a high mortality and novel-targeted treatment strategies have not resulted in breakthroughs for this disease. Insight into the molecular characteristics of ovarian tumors may improve diagnosis and selection of patients for trea ... ... Neoadjuvant chemotherapy in ovarian cancer revisited 2016-05-04T08:00:00Z 2016-05-04T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=210346:neoadjuvant-chemotherapy-ovarian-cancer&catid=1005:Oncologia&Itemid=126 Annals of Oncology - recent issues [email protected]

Oncologia

Despite the recent publication of two randomized controlled phase III trials addressing neoadjuvant chemotherapy in advanced ovarian cancer, the optimal timing of multimodal management in primary therapy is still under debate. As both studies met ... ...

Oncologia

Despite the recent publication of two randomized controlled phase III trials addressing neoadjuvant chemotherapy in advanced ovarian cancer, the optimal timing of multimodal management in primary therapy is still under debate. As both studies met ... ... Anti-angiogenic agents in ovarian cancer: past, present, and future 2016-05-04T08:00:00Z 2016-05-04T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=210347:anti-angiogenic-agents-ovarian&catid=1005:Oncologia&Itemid=126 Annals of Oncology - recent issues [email protected]

Oncologia

Angiogenesis plays a pivotal role in normal ovarian physiology as well as in the progression of ovarian cancer through ascites formation and metastatic spread. Bevacizumab (Avastin®, Genentech; South San Francisco, CA, USA), a huma ... ...

Oncologia

Angiogenesis plays a pivotal role in normal ovarian physiology as well as in the progression of ovarian cancer through ascites formation and metastatic spread. Bevacizumab (Avastin®, Genentech; South San Francisco, CA, USA), a huma ... ... Low-grade serous carcinoma of the ovary or peritoneum 2016-05-04T08:00:00Z 2016-05-04T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=210348:grade-serous-carcinoma-ovary&catid=1005:Oncologia&Itemid=126 Annals of Oncology - recent issues [email protected]

Oncologia

Over the past decade, the strategy for clinical trial design in making progress against epithelial cancers of the ovary/peritoneum/fallopian tube has changed dramatically. The NRG (GOG) Rare Tumor Committee has been a leader in this transformatio ... ...

Oncologia

Over the past decade, the strategy for clinical trial design in making progress against epithelial cancers of the ovary/peritoneum/fallopian tube has changed dramatically. The NRG (GOG) Rare Tumor Committee has been a leader in this transformatio ... ... Clear-cell carcinoma of the ovary 2016-05-04T08:00:00Z 2016-05-04T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=210349:clear-cell-carcinoma-ovary&catid=1005:Oncologia&Itemid=126 Annals of Oncology - recent issues [email protected]

Oncologia

Clear-cell carcinoma of the ovary (CCCO) is a distinct entity of epithelial ovarian cancer in terms of clinical, histopathological, or genetic features. The incidence of CCCO is different by ethnicity but the reason is not clear yet. Overall prog ... ...

Oncologia

Clear-cell carcinoma of the ovary (CCCO) is a distinct entity of epithelial ovarian cancer in terms of clinical, histopathological, or genetic features. The incidence of CCCO is different by ethnicity but the reason is not clear yet. Overall prog ... ...